Prevalence of congenital myopathies in a representative pediatric united states population.
Ann Neurol
; 70(4): 662-5, 2011 Oct.
Article
en En
| MEDLINE
| ID: mdl-22028225
ABSTRACT
The prevalence of congenital myopathies in the United States has not been examined. To address this, we determined the point prevalence of congenital myopathies in a well-defined pediatric population from Southeastern Michigan. The overall point prevalence was 126,000. Mutations in RYR1 were the most common cause of congenital myopathies at 190,000. Our data broadly agrees with estimates from previous European studies and provides the first estimate of the prevalence of congenital myopathies in the United States. Ann Neurol 2011;70662-665.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Canal Liberador de Calcio Receptor de Rianodina
/
Distrofias Musculares
Tipo de estudio:
Prevalence_studies
/
Risk_factors_studies
Límite:
Child
/
Female
/
Humans
/
Male
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Ann Neurol
Año:
2011
Tipo del documento:
Article
País de afiliación:
Estados Unidos